CSPC Pharmaceutical Group Ltd (NASDAQ:CHPTY) was upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating in a report released on Monday. The firm currently has a $82.00 price objective on the stock. Zacks Investment Research‘s target price indicates a potential upside of 2.45% from the company’s current price.
According to Zacks, “CSPC Pharmaceutical Group Limited operates as a pharmaceutical group in China. Its bulk drug products include vitamin C, penicillin G and 7-ACA. The Company is also a major manufacturer of antibiotic finished drugs such as penicillin and cephalosporin products. CSPC Pharmaceutical Group Limited, formerly known as China Pharmaceutical Group Limited, is based in Wan Chai, Hong Kong. “
Shares of CSPC Pharmaceutical Group (NASDAQ:CHPTY) opened at 80.04 on Monday. The firm’s 50-day moving average is $77.53 and its 200 day moving average is $71.62. The stock has a market capitalization of $9.69 billion and a price-to-earnings ratio of 32.02. CSPC Pharmaceutical Group has a 52-week low of $51.03 and a 52-week high of $80.04.
COPYRIGHT VIOLATION NOTICE: “CSPC Pharmaceutical Group Ltd (CHPTY) Stock Rating Upgraded by Zacks Investment Research” was first posted by Week Herald and is the sole property of of Week Herald. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://weekherald.com/2017/10/11/cspc-pharmaceutical-group-ltd-chpty-stock-rating-upgraded-by-zacks-investment-research.html.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs).
Receive News & Ratings for CSPC Pharmaceutical Group Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group Ltd and related companies with MarketBeat.com's FREE daily email newsletter.